© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
November 27, 2021
Individuals from European backgrounds had higher type 1 interferon pathway activity during early influenza infection than individuals with African genetic heritage.
November 26, 2021
COVID-19 vaccines are frequently tested in low- and middle-income countries, but they have experienced significant delays in vaccinating their own populations.
The strain identified as B.1.1.529 is causing some travel restrictions from some African countries.
November 25, 2021
Analysis documents 9% rise in shots distributed after federal officials pushed for vaccination.
November 24, 2021
COVID-19 infection during pregnancy induced immune system rewiring in both mothers and their infants.
The FDA has approved patients 6 months and older to receive Seqirus's first-ever adjuvanted, cell-based influenza vaccine.
Disruptions to health care due to large-scale events, like that of the COVID-19 pandemic, can trickle into so much of what we need for public health, including routine vaccinations.
November 23, 2021
The federal agency's decision makes this the first CMV treatment for this patient population.
In its first real-world study, 2 doses of India’s BBV152 vaccine offered 50% protection against symptomatic COVID-19.
The Scynexis ibrexafungerp (Brexafemme) therapy cleared signs and symptoms of vaginal yeast infection in 73.9% of patients.